Expert Opinion on Drug Discovery, Volume 13, Issue 3 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Discovery, Volume 13, Issue 3 (2018)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Vol 16, 2021 Vol 15, 2020 Vol 14, 2019 Volume 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
Binding modes of hERG blockers: an unsolved mystery in the drug design arena
Subha Kalyaanamoorthy & Khaled H. Barakat
Pages: 207-210
Published online: 18 Dec 2017
First Page PreviewforBinding modes of hERG blockers: an unsolved mystery in the drug design arena | Full Text | References | PDF (563.7 KB)
  • 2893 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Lost in translation? A critical look at the role that animal models of obsessive compulsive disorder play in current drug discovery strategies
Kurt Leroy Hoffman & Hugo Cano-Ramírez
Pages: 211-220
Published online: 23 Dec 2017
AbstractforLost in translation? A critical look at the role that animal models of obsessive compulsive disorder play in current drug discovery strategies | Full Text | References | PDF (741 KB)
  • 333 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician’s perspective
Michele Fornaro, Lubna Kardash, Stefano Novello, Andrea Fusco, Annalisa Anastasia, Domenico De Berardis, Giampaolo Perna & Mauro Giovanni Carta
Pages: 221-228
Published online: 22 Jan 2018
AbstractforProgress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician’s perspective | Full Text | References | PDF (831.9 KB)
  • 193 Views
  • 11 CrossRef citations
  • 0Altmetric
Review
Novel models for Parkinson’s disease and their impact on future drug discovery
Ines Trigo-Damas, Natalia Lopez-Gonzalez del Rey & Javier Blesa
Pages: 229-239
Published online: 24 Jan 2018
AbstractforNovel models for Parkinson’s disease and their impact on future drug discovery | Full Text | References | PDF (1.3 MB)
  • 720 Views
  • 20 CrossRef citations
  • 0Altmetric
Review
Docking studies for melatonin receptors
Hanan Awad Alkozi, José Maria Sánchez Montero, Antonio Luis Doadrio & Jesus Pintor
Pages: 241-248
Published online: 22 Dec 2017
AbstractforDocking studies for melatonin receptors | Full Text | References | PDF (753.4 KB)
  • 223 Views
  • 16 CrossRef citations
  • 0Altmetric
Review
The latest animal models of ovarian cancer for novel drug discovery
Elizabeth Magnotti & Wayne A. Marasco
Pages: 249-257
Published online: 17 Jan 2018
AbstractforThe latest animal models of ovarian cancer for novel drug discovery | Full Text | References | PDF (925.4 KB)
  • 969 Views
  • 37 CrossRef citations
  • 0Altmetric
Review
Urinary peptidomics in kidney disease and drug research
Magdalena Krochmal, Joost P Schanstra & Harald Mischak
Pages: 259-268
Published online: 19 Dec 2017
AbstractforUrinary peptidomics in kidney disease and drug research | Full Text | References | PDF (1.4 MB) | Supplemental
  • 278 Views
  • 16 CrossRef citations
  • 0Altmetric
Review
An update on the advancing high-throughput screening techniques for patch clamp-based ion channel screens: implications for drug discovery
Alison Obergrussberger, Tom A. Goetze, Nina Brinkwirth, Nadine Becker, Søren Friis, Markus Rapedius, Claudia Haarmann, Ilka Rinke-Weiß, Sonja Stölzle-Feix, Andrea Brüggemann, Michael George & Niels Fertig
Pages: 269-277
Published online: 17 Jan 2018
AbstractforAn update on the advancing high-throughput screening techniques for patch clamp-based ion channel screens: implications for drug discovery | Full Text | References | PDF (1.4 MB)
  • 771 Views
  • 40 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
Imane Charmarke-Askar et al.
Review Article | Published online: 22 Jul 2024
What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
Inhibitors and PROTACs of CDK2: challenges and opportunities
Yangjie Zeng et al.
Review Article | Published online: 12 Jul 2024
View all latest articles